vs
Side-by-side financial comparison of EPAM Systems (EPAM) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
EPAM Systems is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× PERRIGO Co plc). EPAM Systems runs the higher net margin — 7.8% vs -127.8%, a 135.6% gap on every dollar of revenue. On growth, EPAM Systems posted the faster year-over-year revenue change (12.8% vs -2.5%). EPAM Systems produced more free cash flow last quarter ($268.1M vs $148.6M). Over the past eight quarters, EPAM Systems's revenue compounded faster (9.9% CAGR vs 1.3%).
EPAM Systems, Inc. is an American company that specializes in software engineering services, digital platform engineering, and digital product design, operating out of Newtown, Pennsylvania. EPAM is a founding member of the MACH Alliance.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
EPAM vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.1B |
| Net Profit | $109.4M | $-1.4B |
| Gross Margin | 30.1% | 32.6% |
| Operating Margin | 10.6% | -116.0% |
| Net Margin | 7.8% | -127.8% |
| Revenue YoY | 12.8% | -2.5% |
| Net Profit YoY | 5.9% | -3093.9% |
| EPS (diluted) | $1.97 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $1.3B | $1.0B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.2B | $1.1B |
| Q4 25 | $109.4M | $-1.4B | ||
| Q3 25 | $106.8M | $7.5M | ||
| Q2 25 | $88.0M | $-8.4M | ||
| Q1 25 | $73.5M | $-6.4M | ||
| Q4 24 | $103.3M | $-44.4M | ||
| Q3 24 | $136.3M | $-21.0M | ||
| Q2 24 | $98.6M | $-108.4M | ||
| Q1 24 | $116.2M | $2.0M |
| Q4 25 | 30.1% | 32.6% | ||
| Q3 25 | 29.5% | 36.1% | ||
| Q2 25 | 28.8% | 34.4% | ||
| Q1 25 | 26.9% | 37.6% | ||
| Q4 24 | 30.4% | 33.9% | ||
| Q3 24 | 34.6% | 37.2% | ||
| Q2 24 | 29.3% | 37.0% | ||
| Q1 24 | 28.4% | 33.1% |
| Q4 25 | 10.6% | -116.0% | ||
| Q3 25 | 10.4% | 7.0% | ||
| Q2 25 | 9.3% | 4.3% | ||
| Q1 25 | 7.6% | 4.5% | ||
| Q4 24 | 10.9% | 10.0% | ||
| Q3 24 | 15.2% | 7.4% | ||
| Q2 24 | 10.5% | -2.5% | ||
| Q1 24 | 9.5% | -5.1% |
| Q4 25 | 7.8% | -127.8% | ||
| Q3 25 | 7.7% | 0.7% | ||
| Q2 25 | 6.5% | -0.8% | ||
| Q1 25 | 5.6% | -0.6% | ||
| Q4 24 | 8.3% | -3.9% | ||
| Q3 24 | 11.7% | -1.9% | ||
| Q2 24 | 8.6% | -10.2% | ||
| Q1 24 | 10.0% | 0.2% |
| Q4 25 | $1.97 | $-10.23 | ||
| Q3 25 | $1.91 | $0.05 | ||
| Q2 25 | $1.56 | $-0.06 | ||
| Q1 25 | $1.28 | $-0.05 | ||
| Q4 24 | $1.80 | $-0.32 | ||
| Q3 24 | $2.37 | $-0.15 | ||
| Q2 24 | $1.70 | $-0.79 | ||
| Q1 24 | $1.97 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.3B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.7B | $2.9B |
| Total Assets | $4.9B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | $432.1M | ||
| Q2 25 | $1.0B | $454.2M | ||
| Q1 25 | $1.2B | $409.9M | ||
| Q4 24 | $1.3B | $558.8M | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $1.8B | $542.8M | ||
| Q1 24 | $2.0B | $658.5M |
| Q4 25 | $3.7B | $2.9B | ||
| Q3 25 | $3.7B | $4.4B | ||
| Q2 25 | $3.7B | $4.5B | ||
| Q1 25 | $3.6B | $4.4B | ||
| Q4 24 | $3.6B | $4.3B | ||
| Q3 24 | $3.6B | $4.6B | ||
| Q2 24 | $3.4B | $4.5B | ||
| Q1 24 | $3.5B | $4.7B |
| Q4 25 | $4.9B | $8.5B | ||
| Q3 25 | $4.8B | $10.1B | ||
| Q2 25 | $4.7B | $10.1B | ||
| Q1 25 | $4.7B | $9.8B | ||
| Q4 24 | $4.8B | $9.6B | ||
| Q3 24 | $4.5B | $11.2B | ||
| Q2 24 | $4.2B | $10.4B | ||
| Q1 24 | $4.4B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $282.9M | $175.4M |
| Free Cash FlowOCF − Capex | $268.1M | $148.6M |
| FCF MarginFCF / Revenue | 19.0% | 13.4% |
| Capex IntensityCapex / Revenue | 1.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $612.7M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $282.9M | $175.4M | ||
| Q3 25 | $294.7M | $51.7M | ||
| Q2 25 | $53.2M | $75.9M | ||
| Q1 25 | $24.2M | $-64.5M | ||
| Q4 24 | $130.3M | $312.6M | ||
| Q3 24 | $242.0M | $42.2M | ||
| Q2 24 | $57.0M | $9.5M | ||
| Q1 24 | $129.9M | $-1.4M |
| Q4 25 | $268.1M | $148.6M | ||
| Q3 25 | $286.4M | $29.8M | ||
| Q2 25 | $43.4M | $56.7M | ||
| Q1 25 | $14.8M | $-90.0M | ||
| Q4 24 | $114.5M | $274.9M | ||
| Q3 24 | $237.0M | $15.1M | ||
| Q2 24 | $52.3M | $-18.9M | ||
| Q1 24 | $123.2M | $-26.5M |
| Q4 25 | 19.0% | 13.4% | ||
| Q3 25 | 20.5% | 2.9% | ||
| Q2 25 | 3.2% | 5.4% | ||
| Q1 25 | 1.1% | -8.6% | ||
| Q4 24 | 9.2% | 24.2% | ||
| Q3 24 | 20.3% | 1.4% | ||
| Q2 24 | 4.6% | -1.8% | ||
| Q1 24 | 10.6% | -2.4% |
| Q4 25 | 1.1% | 2.4% | ||
| Q3 25 | 0.6% | 2.1% | ||
| Q2 25 | 0.7% | 1.8% | ||
| Q1 25 | 0.7% | 2.4% | ||
| Q4 24 | 1.3% | 3.3% | ||
| Q3 24 | 0.4% | 2.5% | ||
| Q2 24 | 0.4% | 2.7% | ||
| Q1 24 | 0.6% | 2.3% |
| Q4 25 | 2.59× | — | ||
| Q3 25 | 2.76× | 6.89× | ||
| Q2 25 | 0.60× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.77× | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 1.12× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EPAM
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
